SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filings

Filing date Form Description Filing Group View
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.